Your browser doesn't support javascript.
loading
Development of tissue-engineered tracheal scaffold with refined mechanical properties and vascularisation for tracheal regeneration.
Khalid, Tehreem; Soriano, Luis; Lemoine, Mark; Cryan, Sally-Ann; O'Brien, Fergal J; O'Leary, Cian.
Afiliación
  • Khalid T; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Soriano L; Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Lemoine M; Advanced Materials and Bioengineering Research (AMBER) Centre, RCSI and Trinity College Dublin, Dublin, Ireland.
  • Cryan SA; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • O'Brien FJ; Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • O'Leary C; Centre for Research in Biomedical Devices (CÚRAM), NUI Galway, Galway, Ireland.
Front Bioeng Biotechnol ; 11: 1187500, 2023.
Article en En | MEDLINE | ID: mdl-37346796
Introduction: Attempted tracheal replacement efforts thus far have had very little success. Major limiting factors have been the inability to efficiently re-vascularise and mimic the mechanical properties of native tissue. The major objective of this study was to optimise a previously developed collagen-hyaluronic acid scaffold (CHyA-B), which has shown to facilitate the growth of respiratory cells in distinct regions, as a potential tracheal replacement device. Methods: A biodegradable thermoplastic polymer was 3D-printed into different designs and underwent multi-modal mechanical assessment. The 3D-printed constructs were incorporated into the CHyA-B scaffolds and subjected to in vitro and ex vivo vascularisation. Results: The polymeric backbone provided sufficient strength to the CHyA-B scaffold, with yield loads of 1.31-5.17 N/mm and flexural moduli of 0.13-0.26 MPa. Angiogenic growth factor release (VEGF and bFGF) and angiogenic gene upregulation (KDR, TEK-2 and ANG-1) was detected in composite scaffolds and remained sustainable up to 14 days. Confocal microscopy and histological sectioning confirmed the presence of infiltrating blood vessel throughout composite scaffolds both in vitro and ex vivo. Discussion: By addressing both the mechanical and physiological requirements of tracheal scaffolds, this work has begun to pave the way for a new therapeutic option for large tracheal defects.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Año: 2023 Tipo del documento: Article País de afiliación: Irlanda

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Año: 2023 Tipo del documento: Article País de afiliación: Irlanda